Endonovo's SofPulse® Secures Taiwan FDA Approval
October 12, 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) US-based medical device company, today announced the full regulatory approval of its flagship product,...
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
August 08, 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) -- commercial developer of medical technology-- is proud to announce a series of advancements in the first...
Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman
April 13, 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 13, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a commercial stage developer of non-invasive medical devices, is pleased to announce its partnership...
Endonovo Announces Partnership with Santana Lead Singer Andy Vargas
April 10, 2023 12:01 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 10, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc (OTCQB: ENDV) -- a pioneer in bioelectronic medical devices -- announced today its partnership with world-renowned...
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan
March 23, 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 23, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a medical device company known for its innovative and effective pain management solutions --...
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off
January 31, 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the retention of Ocean Tomo, a part of J.S. Held, to conduct a fairness opinion analysis...
Endonovo Partners with International Distributor for SofPulse® Line
January 26, 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Partnership Expected to Increase SofPulse® Distribution and Revenues Los Angeles, CA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced a new...